Background: Few studies have investigated the relationship between subjective cognitive concerns and objective cognitive decline in the oldest-old or examined gender differences. We evaluated this association and stratification by gender in a diverse cohort of adults ages 90+.
Methods: LifeAfter90 is an ongoing cohort of adults ages 90+. Verbal episodic memory (VEM) and executive function (EF) were assessed every 6-months since 2018 using the Spanish and English Neuropsychological Assessment Scales. We operationalized subjective cognition two ways: 1) Dichotomously as yes/no via self-report of subjective memory concerns (SMC)- "are you concerned that you have a memory or other thinking problem?"; 2) Continuously as degree of self-rated changes in cognition using the 16-item Everyday Cognition Scale (ECog). Linear mixed models with random intercepts and slopes estimated associations of SMC or ECog with VEM and EF at baseline and longitudinally, pooled and stratified by gender (female/male). Models adjusted for baseline age, gender (in pooled models), race/ethnicity, education, interview mode (in-person or phone), and practice effects. Sensitivity models further stratified by SMC.
Results: Participants' (N = 499) mean baseline age 93±2.4 years, mean follow-up time 2.7±1.1 years, 62% women, 64% racial/ethnic minorities, 41% endorsed SMC, and mean ECog score 1.45±0.5. Overall, SMC and ECog were associated with worse baseline VEM (β = -0.44,95%CI -0.61,-0.27; β = -0.40,95%CI -0.58,-0.22) and worse baseline EF (β = -0.23,95%CI -0.39,-0.07; β = -0.43,95%CI -0.59,-0.27) (Table 2). ECog was associated with greater decline in EF (β = -0.05, 95%CI -0.10,0.00; Table 2). There were no gender differences in associations between SMC (p = 0.44) or ECog (p = 0.33) and VEM, nor ECog and EF (p = 0.76). The association between SMC and EF differed across genders (p = 0.01). In gender-stratified models, both genders with SMC had worse baseline VEM and worse baseline EF, though not significantly for women (β = -0.54,95%CI -0.79,-0.29; β = -0.07,95%CI -0.27,0.13) (Table 2). Both genders with greater ECog had worse baseline VEM (β = -0.56,95%CI -0.87,-0.26; β = -0.33,95%CI -0.56,-0.10) and worse baseline EF (β = -0.43,95%CI -0.70,-0.14; β = -0.41,95%CI -0.61,-0.22) (Table 2). After stratification by SMC, among those with SMC, ECog was associated with worse baseline EF (β = -0.47,95%CI -0.68,-0.26; Table 2).
Conclusion: In this diverse cohort of 90+, the association between subjective memory concerns and worse baseline EF was more pronounced in men than in women.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/alz.091848 | DOI Listing |
Background: Paroxysmal sympathetic hyperactivity (PSH) occurs with high prevalence among critically ill patients with traumatic brain injury (TBI) and is associated with worse outcomes. The PSH-Assessment Measure (PSH-AM) consists of a Clinical Features Scale and a diagnosis likelihood tool (DLT) intended to quantify the severity of sympathetically mediated symptoms and the likelihood that they are due to PSH, respectively, on a daily basis. Here, we aim to identify and explore the value of dynamic trends in the evolution of sympathetic hyperactivity following acute TBI using elements of the PSH-AM.
View Article and Find Full Text PDFRMD Open
January 2025
CIC, Epidémiologie Clinique, INSERM, Nancy University Hospital Center, Nancy, Grand Est, France.
Objective: The objective of this study was to analyse the association between body composition and changes in health-related quality of life (HRQoL) of patients followed for hip and knee osteoarthritis (OA).
Methods: Longitudinal data from the Knee and Hip OsteoArthritis Long-term Assessments (KHOALA) cohort, a multicentre cohort of 878 patients with symptomatic knee and/or hip OA, were used. The main outcome criteria were changes in patient-reported outcomes measures, the Study Short Form-36 (physical functioning, pain, mental health and vitality) and the OsteoArthritis Knee and Hip Quality Of Life (OAKHQOL)(physical activity, pain and mental health).
Objective: The objective of this study was to assess the complicated relationship between frailty, perioperative complications, and patient-reported outcomes (PROs) in elderly patients (≥ 75 years old) undergoing lumbar spine fusion (LSF).
Methods: Consecutive patients who underwent LSF between March 2019 and December 2021 were recruited in this study. Frail patients (modified frailty index [mFI] score ≥ 2) were propensity score matched to nonfrail patients (mFI score 0-1) on the basis of age, sex, and the number of fused levels.
Alzheimers Dement
December 2024
Boston University Alzheimer's Disease Research Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Background: There is growing evidence that epigenetic age acceleration may predict late life cognitive decline and dementia, but it is unknown whether this is due to accelerated neurodegeneration or reduction in cognitive resilience. We examined the relationship between epigenetic clocks and domain specific neuropsychological (NP) factor scores, mild cognitive impairment (MCI), Alzheimer's Disease (AD), and all-cause dementia, before and after accounting for plasma total tau (t-tau), a marker of neurodegeneration.
Method: DNA methylation and plasma t-tau (Simoa assay; Quanterix) data from 2091 Framingham Heart Study Offspring cohort participants were generated from blood at the same Exam 8 visit (2005-2008).
Alzheimers Dement
December 2024
The Framingham Heart Study, Framingham, MA, USA.
Background: The long-term neurological impact of the SARS-CoV-2 virus is unknown and it remains to be seen whether it would create a surge in cases of dementia and cognitive decline years later, which is already a global public health challenge. Our group has previously shown that participants cognitive functioning as measured via mobile-based assessments using smartphone-based cognitive tests did not differ based on their COVID status. The goal of the present study was to examine participants longitudinal cognitive performance with the hypothesis that participants with a previous COVID-19 diagnosis (COVID+) will have worse cognitive performance over time than those without COVID-19 (COVID-).
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!